MX2010013152A - Formulaciones farmaceuticas topicas que contienen una baja concentracion de peroxido de benzoilo en suspension en agua y un solvente organico miscibe en agua. - Google Patents

Formulaciones farmaceuticas topicas que contienen una baja concentracion de peroxido de benzoilo en suspension en agua y un solvente organico miscibe en agua.

Info

Publication number
MX2010013152A
MX2010013152A MX2010013152A MX2010013152A MX2010013152A MX 2010013152 A MX2010013152 A MX 2010013152A MX 2010013152 A MX2010013152 A MX 2010013152A MX 2010013152 A MX2010013152 A MX 2010013152A MX 2010013152 A MX2010013152 A MX 2010013152A
Authority
MX
Mexico
Prior art keywords
formulation
benzoyl peroxide
water
organic solvent
concentration
Prior art date
Application number
MX2010013152A
Other languages
English (en)
Spanish (es)
Inventor
Gordon J Down
Yunik Chang
Original Assignee
Dow Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41398394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010013152(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dow Pharmaceutical Sciences filed Critical Dow Pharmaceutical Sciences
Publication of MX2010013152A publication Critical patent/MX2010013152A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/33—Free of surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2010013152A 2008-06-05 2009-06-03 Formulaciones farmaceuticas topicas que contienen una baja concentracion de peroxido de benzoilo en suspension en agua y un solvente organico miscibe en agua. MX2010013152A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13101408P 2008-06-05 2008-06-05
PCT/US2009/003367 WO2009148584A1 (en) 2008-06-05 2009-06-03 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

Publications (1)

Publication Number Publication Date
MX2010013152A true MX2010013152A (es) 2011-05-02

Family

ID=41398394

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010013152A MX2010013152A (es) 2008-06-05 2009-06-03 Formulaciones farmaceuticas topicas que contienen una baja concentracion de peroxido de benzoilo en suspension en agua y un solvente organico miscibe en agua.

Country Status (15)

Country Link
US (13) US8288434B2 (enExample)
EP (1) EP2299810B1 (enExample)
JP (2) JP5677693B2 (enExample)
KR (1) KR20110014651A (enExample)
CN (1) CN102056481A (enExample)
AU (1) AU2009255679B2 (enExample)
BR (1) BRPI0913326C1 (enExample)
CA (1) CA2723029C (enExample)
ES (1) ES2773931T3 (enExample)
HR (1) HRP20200450T1 (enExample)
MX (1) MX2010013152A (enExample)
PT (1) PT2299810T (enExample)
RU (2) RU2493847C2 (enExample)
WO (1) WO2009148584A1 (enExample)
ZA (1) ZA201008265B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0614143A2 (pt) 2005-08-02 2012-11-20 Sol Gel Technologies Ltd processo para revestir um material particulado insolével em Água, sàlido, com um àxido metÁlico, material particulado revestido, composiÇço, mÉtodo para o tratamento de uma condiÇço superficial em um induvÍduo, e, uso de material particulado revestido
ES2763829T3 (es) 2007-02-01 2020-06-01 Sol Gel Tech Ltd Método para preparar partículas que comprenden un revestimiento de óxido de metal
ES2773931T3 (es) 2008-06-05 2020-07-15 Bausch Health Ireland Ltd Formulaciones farmacéuticas tópicas que contienen una baja concentración de peróxido de benzoílo en suspensión en agua y un solvente orgánico miscible en agua
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
WO2010047784A1 (en) * 2008-10-20 2010-04-29 Dow Pharmaceutical Sciences, Inc. Method for obtaining a stable dispersion of benzoyl peroxide
CA2777489C (en) * 2009-10-21 2018-11-20 Dow Pharmaceutical Sciences, Inc. Method for wetting a powder containing benzoyl peroxide
US9744150B2 (en) * 2009-10-21 2017-08-29 Dow Pharmaceutical Sciences Inc. Suspension containing micronized benzoyl peroxide
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP2925296B1 (en) * 2012-11-27 2021-01-06 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2017068673A1 (ja) * 2015-10-21 2017-04-27 マルホ株式会社 皮膚用の医薬組成物
CN107304177B (zh) * 2016-04-20 2020-09-15 武汉诺安药业有限公司 一种过氧苯甲酰微粉化的化学制备方法
HUE073201T2 (hu) 2017-07-12 2026-01-28 Sol Gel Tech Ltd Kapszulázott tretinoint tartalmazó készítmények
CA3070663A1 (en) * 2017-07-21 2019-01-24 Almirall, Llc Treatment of non-inflammatory lesions
CN107375209A (zh) * 2017-08-30 2017-11-24 江苏嘉逸医药有限公司 一种过氧苯甲酰的局部药物制剂
CN107737135A (zh) * 2017-11-28 2018-02-27 江苏万川医疗健康产业集团有限公司 一种药物制剂及其制备方法与应用
JP6811213B2 (ja) * 2018-07-03 2021-01-13 ソル − ゲル テクノロジーズ リミテッド 酒さの治療のための組成物
US11628155B2 (en) 2019-02-19 2023-04-18 Sol-Gel Technologies Ltd. Method for therapeutic treatment of rosacea
CN114126582A (zh) 2019-08-01 2022-03-01 博世健康爱尔兰有限公司 局部用组合物
CN113577022B (zh) * 2021-05-18 2023-03-17 南京欣通瑞亿医药科技有限公司 一种氨苯砜类化合物混悬液及其制备方法和应用
EP4523677A1 (en) 2023-09-13 2025-03-19 Dr. Pfleger Arzneimittel GmbH Topical composition of nadifloxacin and benzoyl peroxide

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535442A (en) 1967-10-19 1970-10-20 John E Jennings Anti-shoplifting and surveillance system
US4056611A (en) 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US4497794A (en) * 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4075353A (en) 1976-06-09 1978-02-21 Dermatologics For Veterinary Medicine, Inc. Process for the treatment of acarid skin infections in animals
FR2378523A1 (fr) 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne
US4189501A (en) 1977-10-07 1980-02-19 A. H. C. Pharmacal, Inc. Composition and method for the treatment of acne
NZ194326A (en) 1979-07-25 1982-05-31 Dermik Lab Inc Stable aqueous benzoyl peroxide compositions and therapeutic compositions
US4387107A (en) 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
IT1210608B (it) * 1980-12-08 1989-09-14 Rorer Int Overseas Composizione per il trattamento topico dell'acne
US4411893A (en) 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4401835A (en) * 1981-09-17 1983-08-30 Warner-Lambert Company Method for preparing small sized benzoyl peroxide crystals
US4923900A (en) * 1985-01-24 1990-05-08 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
FR2604435B1 (fr) 1986-09-30 1988-12-02 Oreal Peroxydes aromatiques insatures et leur utilisation en therapeutique et cosmetique
US6117843A (en) * 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
IL105217A0 (en) 1992-04-09 1993-07-08 Allergan Inc Method and composition for treating acne
US5466446A (en) * 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5470884A (en) 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
DE4418096A1 (de) 1994-05-24 1995-11-30 Cassella Ag Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase
US5445823A (en) 1994-10-20 1995-08-29 The Procter & Gamble Company Dermatological compositions and method of treatment of skin lesions therewith
US20020039561A1 (en) 1995-11-15 2002-04-04 Doughty Darrell Gene Topical skin care compositions containing thickened polyol carboxylic acid esters as skin conditioning agents
US6071541A (en) * 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
US6433024B1 (en) 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6837383B1 (en) 2001-01-25 2005-01-04 Mcelhaney Jr Wayne Tool organizer mounted to a vehicle lift rack
US20030064084A1 (en) 2001-09-24 2003-04-03 Bradley Pharmaceuticals, Inc. Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US20040101566A1 (en) 2002-02-04 2004-05-27 Elan Pharma International Limited Novel benzoyl peroxide compositions
WO2004064833A1 (en) 2003-01-24 2004-08-05 Connetics Australia Pty Ltd. Clindamycin phosphate foam
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
US20050239723A1 (en) * 2004-04-27 2005-10-27 Amin Avinash N Compositions and methods useful for treatment of acne
US7153888B2 (en) * 2004-12-21 2006-12-26 Alpharx Inc. Stabilization of benzoyl peroxide in solution
CA2600547A1 (en) * 2005-03-10 2006-09-21 Jr Chem, Llc Benzoyl peroxide compositions and methods of use
AR054805A1 (es) 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Research Australia Pty Ltd. gel de suspensão espumante
MXPA06008988A (es) 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
EP1967180A1 (de) 2007-03-06 2008-09-10 Almirall Hermal GmbH Topische Zusammensetzung enthaltend einen Retinoid-Rezeptor-Agonist
ES2773931T3 (es) * 2008-06-05 2020-07-15 Bausch Health Ireland Ltd Formulaciones farmacéuticas tópicas que contienen una baja concentración de peróxido de benzoílo en suspensión en agua y un solvente orgánico miscible en agua
DE202012013021U1 (de) * 2011-12-09 2014-11-28 Mary Kay Inc. Hautpflegeformulierung
BR112021018503A2 (pt) * 2019-03-18 2021-11-30 Bausch Health Ireland Ltd Composições tópicas e métodos para tratar acne vulgar

Also Published As

Publication number Publication date
US8895070B2 (en) 2014-11-25
RU2013122395A (ru) 2014-11-20
JP5677693B2 (ja) 2015-02-25
US20170216336A1 (en) 2017-08-03
US20140051649A1 (en) 2014-02-20
US20130012460A1 (en) 2013-01-10
ES2773931T3 (es) 2020-07-15
RU2645087C2 (ru) 2018-02-15
PT2299810T (pt) 2020-03-04
BRPI0913326B1 (pt) 2019-07-30
AU2009255679B2 (en) 2015-04-09
ZA201008265B (en) 2011-08-31
US20160220528A1 (en) 2016-08-04
US20130236549A1 (en) 2013-09-12
EP2299810B1 (en) 2020-01-01
BRPI0913326A2 (pt) 2015-09-15
CN102056481A (zh) 2011-05-11
US11478498B2 (en) 2022-10-25
JP2011522820A (ja) 2011-08-04
US8288434B2 (en) 2012-10-16
US20140050792A1 (en) 2014-02-20
RU2010146038A (ru) 2012-07-27
US10137142B2 (en) 2018-11-27
US20090306172A1 (en) 2009-12-10
US8663699B2 (en) 2014-03-04
RU2493847C2 (ru) 2013-09-27
CA2723029A1 (en) 2009-12-10
CA2723029C (en) 2016-07-19
BRPI0913326C1 (pt) 2021-05-25
HRP20200450T1 (hr) 2020-06-26
BRPI0913326B8 (pt) 2019-09-03
AU2009255679A1 (en) 2009-12-10
US20170165220A1 (en) 2017-06-15
EP2299810A1 (en) 2011-03-30
US20140235560A1 (en) 2014-08-21
US20140134252A1 (en) 2014-05-15
US9693988B2 (en) 2017-07-04
US20200276218A1 (en) 2020-09-03
JP6006272B2 (ja) 2016-10-12
KR20110014651A (ko) 2011-02-11
US9504704B2 (en) 2016-11-29
US20230047106A1 (en) 2023-02-16
JP2015038093A (ja) 2015-02-26
US10220049B2 (en) 2019-03-05
US20190125776A1 (en) 2019-05-02
US10624918B2 (en) 2020-04-21
EP2299810A4 (en) 2013-11-13
US9078870B2 (en) 2015-07-14
WO2009148584A1 (en) 2009-12-10
US9561208B2 (en) 2017-02-07

Similar Documents

Publication Publication Date Title
US11478498B2 (en) Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
US10350166B2 (en) Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US20100029765A1 (en) Topical aqueous composition comprising tretinoin
JP2009500336A (ja) 局所用皮膚治療組成物
CN105209051A (zh) 痤疮溶液
US20090131521A1 (en) Aqueous retinoid and benzoyl peroxide gel
US20050255133A1 (en) Topical composition for acne treatment
MX2010012755A (es) Nuevas composiciones despigmentantes anhidras que comprenden un derivado fenolico solubilizado.
JP2018529723A (ja) イベルメクチンを含むすすぎのいらないケミカルフォーム

Legal Events

Date Code Title Description
FG Grant or registration